Physician profile
Sailaja Allamneni
NPI 1780974816
$830.00
in general payments reported to CMS, 2019-2025
22 companies · $309 in 2025
The $309 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.85 · 2020: $14.15 · 2021: $75.33 · 2023: $263 · 2024: $153 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $708 · Education: $16.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $708.43 |
| Education | $16.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $135.55 | 2023-2024 | Inspire |
| Astrazeneca Pharmaceuticals LP | $114.00 | 2019-2025 | Tezspire, Breztri, Fasenra |
| Insmed, INC. | $63.02 | 2025 | Arikayce |
| Philips North America LLC | $62.72 | 2023-2025 | Vest Therapy Und |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.49 | 2025 | Ofev |
| Actelion Pharmaceuticals US, INC. | $33.57 | 2023 | Uptravi |
| Pulmonx Corporation | $32.91 | 2024-2025 | Chartis Catheter, Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter |
| Phadia US INC. | $32.84 | 2023-2025 | Immunocap |
| Advanced Respiratory, INC | $30.62 | 2021 | |
| United Therapeutics Corporation | $28.74 | 2023 | Tyvaso |
| Grifols USA, LLC | $27.88 | 2025 | Prolastin-C Liquid |
| Abiomed | $27.33 | 2023 | Impella |
| Takeda Pharmaceuticals U.S.A., INC. | $23.83 | 2024 | Glassia |
| Glaxosmithkline, LLC. | $23.15 | 2023 | Nucala |
| Vapotherm INC | $22.08 | 2023 | Vapotherm |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $21.94 | 2023 | Hillrom - Life 2000 Ventilation System |
| Bayer Healthcare Pharmaceuticals INC. | $21.01 | 2025 | |
| Itamar Medical INC | $19.82 | 2023 | Watchpatone |
| Mylan Specialty L.P. | $18.00 | 2021 | |
| Axsome Therapeutics, INC. | $17.79 | 2023 | Sunosi |
| Melinta Therapeutics, LLC | $15.45 | 2021 | |
| Masimo Corporation | $11.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sailaja Allamneni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.